In addition, NFKB2 was found to be upregulated, the p100 subunit of nuclear factor NF-kappa-B, a key regulator of inflammatory responses in the liver that drives the regulation of many genes reported to play a role in atherosclerosis development [30]. This evidence concerns the gene NFKB2 and atherosclerosis.